Ancrod for coronary angioplasty.
AUTOR(ES)
Pothoulakis, A J
RESUMO
Anticoagulation in the form of intravenous heparin is used after coronary angioplasty to prevent thrombosis. Ancrod, a rapid-acting defibrinogenating agent, has been used in various clinical settings that require anticoagulation. We present the use of ancrod after percutaneous transluminal coronary angioplasty in a patients with heparin-induced thrombopathia.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=325287Documentos Relacionados
- Combining coronary angiography and angioplasty.
- Desirability of immediate surgical standby for coronary angioplasty.
- Benign coronary perforation during percutaneous transluminal coronary angioplasty.
- Acute coronary occlusion during percutaneous transluminal coronary angioplasty.
- Coronary sinus potassium concentration recorded during coronary angioplasty.
